Acadia Healthcare Company Inc (NASDAQ: ACHC)’s stock price has decreased by -6.27 compared to its previous closing price of 72.99. However, the company has seen a -6.77% decrease in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-05-01 that Acadia Healthcare (ACHC) came out with quarterly earnings of $0.84 per share, beating the Zacks Consensus Estimate of $0.80 per share. This compares to earnings of $0.75 per share a year ago.
Is It Worth Investing in Acadia Healthcare Company Inc (NASDAQ: ACHC) Right Now?
Moreover, the 36-month beta value for ACHC is 1.35. Analysts have varying opinions on the stock, with 4 analysts rating it as a “buy,” 6 as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for ACHC is 89.71M and currently, short sellers hold a 3.92% of that float. On May 02, 2024, ACHC’s average trading volume was 591.42K shares.
ACHC’s Market Performance
ACHC’s stock has seen a -6.77% decrease for the week, with a -9.77% drop in the past month and a -16.33% fall in the past quarter. The volatility ratio for the week is 2.17%, and the volatility levels for the past 30 days are at 2.13% for Acadia Healthcare Company Inc The simple moving average for the past 20 days is -6.43% for ACHC’s stock, with a -10.48% simple moving average for the past 200 days.
Analysts’ Opinion of ACHC
Many brokerage firms have already submitted their reports for ACHC stocks, with Deutsche Bank repeating the rating for ACHC by listing it as a “Hold.” The predicted price for ACHC in the upcoming period, according to Deutsche Bank is $70 based on the research report published on April 25, 2024 of the current year 2024.
Barclays, on the other hand, stated in their research note that they expect to see ACHC reach a price target of $100. The rating they have provided for ACHC stocks is “Overweight” according to the report published on March 06th, 2024.
Cantor Fitzgerald gave a rating of “Neutral” to ACHC, setting the target price at $83 in the report published on April 21st of the previous year.
ACHC Trading at -11.82% from the 50-Day Moving Average
After a stumble in the market that brought ACHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.05% of loss for the given period.
Volatility was left at 2.13%, however, over the last 30 days, the volatility rate increased by 2.17%, as shares sank -8.38% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -17.93% lower at present.
During the last 5 trading sessions, ACHC fell by -6.33%, which changed the moving average for the period of 200-days by -7.53% in comparison to the 20-day moving average, which settled at $72.80. In addition, Acadia Healthcare Company Inc saw -12.02% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ACHC starting from Miquelon Wade D, who sale 2,203 shares at the price of $85.39 back on Mar 05 ’24. After this action, Miquelon Wade D now owns 46,074 shares of Acadia Healthcare Company Inc, valued at $188,114 using the latest closing price.
Gregg Vicky B, the Director of Acadia Healthcare Company Inc, sale 2,500 shares at $85.56 during a trade that took place back on Mar 04 ’24, which means that Gregg Vicky B is holding 26,851 shares at $213,900 based on the most recent closing price.
Stock Fundamentals for ACHC
Current profitability levels for the company are sitting at:
- 0.65 for the present operating margin
- 0.63 for the gross margin
The net margin for Acadia Healthcare Company Inc stands at -0.0. The total capital return value is set at 0.39. Equity return is now at value -0.40, with -0.21 for asset returns.
Based on Acadia Healthcare Company Inc (ACHC), the company’s capital structure generated 0.41 points at debt to capital in total, while cash flow to debt ratio is standing at 0.05. The debt to equity ratio resting at 0.69. The interest coverage ratio of the stock is 21.7.
Currently, EBITDA for the company is 638.95 million with net debt to EBITDA at 2.89. When we switch over and look at the enterprise to sales, we see a ratio of 2.75. The receivables turnover for the company is 7.75for trailing twelve months and the total asset turnover is 0.54. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.27.
Conclusion
To wrap up, the performance of Acadia Healthcare Company Inc (ACHC) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
